SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-194765
Filing Date
2017-06-05
Accepted
2017-06-05 17:07:45
Documents
3
Effectiveness Date
2017-06-05

Document Format Files

Seq Description Document Type Size
1 S-8 d380820ds8.htm S-8 37615
2 EX-5.1 d380820dex51.htm EX-5.1 4875
3 EX-23.2 d380820dex232.htm EX-23.2 1277
  Complete submission text file 0001193125-17-194765.txt   44786
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218511 | Film No.: 17892022
SIC: 2835 In Vitro & In Vivo Diagnostic Substances